According to our new research study on “US Lymphedema Treatment Market Forecast to 2028 – COVID-19 Impact and Country Analysis – by Condition Type, Treatment Type, End User, and Geography,” the market is expected to grow from US$ 5,185.98 million in 2022 to US$ 8,320.07 million by 2028; it is estimated to record a CAGR 8.2% during 2023–2028. Factors driving the US lymphedema treatment market growth are the rising incidence of lymphedema cases and increasing healthcare services and lymphedema management programs. However, a lack of awareness and skilled professionals restricts the growth of the market.

Lymphedema is a condition in which the body enlarges abnormally due to the lymphocytosis caused by lymphatic system dysfunction. It most commonly affects the lower extremity (90%), upper extremity (10%), and genitalia (1%).

Rising Treatment Options Drives US Lymphedema Treatment Market Growth

According to the American College of Cardiology Foundation report, treatment of lymphedema is primarily driven by symptom management, volume reduction, and infection prevention. For example, the first line of treatment for lymphedema is conservative management. Complete decongestive therapy (CGT) has become the forefront of physiotherapeutic conservative management. Additionally, surgical treatment approaches provide good adherence to conservative management. Moreover, the new minimally invasive vascularized lymph node transfer for lymphedema has gained significant attention worldwide. For example, physicians at Mayo Clinic's campus in Phoenix/Scottsdale, Arizona, have developed a new outpatient surgical procedure for patients experiencing lymphedema refractory to traditional therapy. Benefits associated with lymph node transfer involve a significant reduction of pain and swelling in the lymphedemic anatomy. Also, the surgery allows patients to decrease their antibiotic use, adding quality-of-life benefits among the patient pool. Further, patients diagnosed with breast, skin penile, bladder, and gynecological cancers may undergo lymph nodes procedure.

Lymphedema is a chronic, incurable disease affecting a patient's physical and mental well-being. Term-based care proves to be a multidisciplinary approach for patient management. The term-based care team includes people from physical rehabilitation, vascular medicine, plastic surgery, radiology, oncology, infectious disease, and social work. The team can provide a thorough evaluation for assessing the etiology of limb swelling, optimizing conservative care, and offering surgical treatment for appropriate candidates.

MedStar Health report states that a patient's lymphedema treatment plans will depend on the cause and severity of the condition. Doctors may prescribe medication or refer to a physical or occupational therapist specializing in the management of lymphedema. Therapies include reducing swelling and controlling pain through exercises, special massage techniques, or mechanical pumping devices. If a patient's condition is severe, doctors may recommend more advanced treatments such as lymph node transfer and lymphovenous bypass.

Furthermore, innovative treatment options such as rehabilitation programs prove beneficial for lymphedema treatment among the patient pool. For example, the LifeSpan Health System report states that outpatient rehabilitation offers programs and different services for individuals for proper management and lucrative benefits for patients suffering from lymphedema swelling or an abnormal accumulation of fluid beneath the skin due to a problem with the lymphatic system. Such innovative treatment options will significantly reduce the rising prevalence of lymphedema by giving promising results in the near future.

Based on end user, the US lymphedema treatment market is segmented into hospitals, clinics, clinical research organizations (CROs), and others (ambulatory care centers and primary care centers). The hospital segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period due to the launch of several innovative products for maximum utilization in hospitals. In September 2020, Paul Hartmann partnered with Apollo Hospitals Group in India and West China Hospitals with a prime focus on the operation of wound care clinics and ambulances, medical training, and products and services. Such strategic steps provide companies to expand their product portfolio in the market. However, the clinics segment is expected to grow at the fastest rate during the coming years.

Impact of COVID-19 Pandemic on US Lymphedema Treatment Market

The prolonged shut-in situation is devastating news for countless industries impacted by business closures, but there are bright spots for sectors that have thrived amid the global health crisis so far.

Lymphedema patients' health care was greatly affected by the COVID-19 lockdown not only from a medical perspective but also from a psychosocial perspective. Identifying and dealing with all these implications properly is crucial to avoiding concerns and consequences resulting from future pandemic lockdowns. To meet the needs of patients suffering from lymphedema, lymphedema services should be well prepared to be delivered virtually, enabling effective care, and shared knowledge.

Biocompression Systems, Tactile Medical, Essity AB, Lohmann & Rauscher GmbH & Co. KG, Sigvaris Group, ThermoTek Inc., Huntleigh Healthcare Limited, 3M Co, AIROS Medical, and Paul Hartmann AG are among the key companies operating in the US lymphedema treatment market. Leading players adopt strategies such as the launch of new products, expansion and diversification of their market presence, and expansion of new customer base for tapping prevailing business opportunities.

The report segments US lymphedema treatment market as follows:

The US lymphedema treatment market is segmented on the basis of condition type, treatment type, and others. Based on the condition type, the market is segmented into primary lymphedema and secondary lymphedema. Based on treatment type, the US lymphedema treatment market is segmented into laser therapy, compression devices & bandaging, drug therapy, physiological procedures, debulking procedures, and others. By end user, the US lymphedema treatment market is segmented into hospitals, clinics, clinical research organizations, and others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com